Finance

Lists
603233:SHA
Dashenlin Pharmaceutical Group Co Ltd
CNยฅ20.82
+0.14%
(+0.030) 1D
Nov 17, 3:00:00โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603233...
Open
CNยฅ20.79
High
CNยฅ21.08
Low
CNยฅ20.49
Mkt. cap
24.54B
Avg. vol.
15.39M
Volume
12.66M
Dividend
4.32%
Quarterly dividend
CNยฅ0.22
Ex-dividend date
Oct 19, 2026
P/E ratio
16.63
52-wk high
CNยฅ21.78
52-wk low
CNยฅ14.39
EPS
CNยฅ1.25
Shares outstanding
400.01M
No. of employees
41K
Open
CNยฅ20.79
High
CNยฅ21.08
Low
CNยฅ20.49
Mkt. cap
24.54B
Avg. vol.
15.39M
Volume
12.66M
Dividend
4.32%
Quarterly dividend
CNยฅ0.22
Ex-dividend date
Oct 19, 2026
P/E ratio
16.63
52-wk high
CNยฅ21.78
52-wk low
CNยฅ14.39
EPS
CNยฅ1.25
Shares outstanding
400.01M
No. of employees
41K
News stories
From web sources and news partners
About Dashenlin Pharmaceutical Group Co Ltd
CEO-
Employees41.1K
FoundedFeb 12, 1999
Headquarters-
SectorConsumer Staples
IndustryDrug
Websitedslyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
7.43B
6.97B
7.02B
7.32B
Cost of goods sold
5.01B
4.46B
4.55B
4.85B
Cost of revenue
5.01B
4.46B
4.55B
4.85B
Research and development expenses
-4.51M
9.63M
8.93M
9.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.95B
1.75B
1.78B
1.88B
Operating expense
2.04B
1.78B
1.81B
1.92B
Total operating expenses
7.05B
6.24B
6.36B
6.77B
Operating income
384.54M
733.21M
659.32M
551.48M
Other non operating income
-641.08K
-7.75M
-5.96M
-64.49M
EBT including unusual items
327.29M
707.02M
616.46M
472.48M
EBT excluding unusual items
360.61M
707.78M
621.99M
464.96M
Income tax expense
128.00M
163.45M
158.22M
106.36M
Effective tax rate
39.11%
23.12%
25.67%
22.51%
Other operating expenses
73.22M
22.65M
28.91M
19.16M
Net income
154.25M
511.14M
415.56M
344.15M
Net profit margin
2.07%
7.33%
5.92%
4.70%
Earnings per share
0.13
0.45
-
0.30
Interest and investment income
17.56M
17.38M
12.36M
14.86M
Interest expense
-40.14M
-35.06M
-43.73M
-36.89M
Net interest expenses
-22.59M
-17.69M
-31.37M
-22.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
451.17M
799.84M
731.60M
618.11M
Gain or loss from assets sale
-14.70M
-
-5.03M
5.03M
Upcoming events
AI content may include mistakes. Learn more
Google apps